Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06874894
Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)
Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine
View on ClinicalTrials.gov
Summary
This study was design to investigate the efficacy and safety of NOAC therapy in Koreans
Official title: Thromboembolic and Bleeding Risk During Anticoagulant Treatment in Asian Patents With Atrial Fibrillation
Key Details
Gender
All
Age Range
18 Months - Any
Study Type
OBSERVATIONAL
Enrollment
1021
Start Date
2022-05-25
Completion Date
2026-08-30
Last Updated
2025-12-29
Healthy Volunteers
No
Conditions
Locations (2)
Chung-Ang University Gwangmyeong Hospital
Gwangmyeong, South Korea
Chung-Ang University Hospital
Seoul, South Korea